3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Classical hematology
1
Conditions
Prostatic Neoplasms
1
Osteoporosis
1
Hot Flashes
1
Anemia
1
Interventions
Epoetin Alfa
55
Darbepoetin alfa
39
epoetin beta
14
ferric carboxymaltose
11
Lenalidomide
5
Cyclophosphamide
5
luspatercept
4
fludarabine phosphate
4
fludarabine
4
Erythropoietin
4
Cyclosporine
4
Cisplatin
4
Busulfan
4
Blood Transfusion
4
Biopsy
4
ACE-011
4
peginesatide
3
iron isomaltoside 1000
3
hematide
3
ferrous sulfate
3
ferric gluconate
3
Radiotherapy
3
Iron-Dextran Complex
3
Filgrastim
3
Ferric Oxide, Saccharated
3
Erythrocyte Transfusion
3
Antilymphocyte Serum
3
thymoglobulin
2
telapristone acetate
2
ruxolitinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Anemia
×
Goserelin
×
Classical hematology
×
Clear all
NCT00303784
2020-11-27
PATCH
University College, London
Phase 3
Unknown
2,200 enrolled